New combo attack on tough liver cancer
NCT ID NCT04238637
Summary
This study is testing whether adding immunotherapy drugs to a standard targeted radiation treatment can better control advanced bile duct cancer that is confined to the liver. It will involve about 50 patients who have already tried standard chemotherapy. Patients will receive the radiation treatment first, then be assigned to receive one or two immunotherapy drugs to see which approach is more effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinic Essen Center
Essen, Germany
-
Hannover Medical School
Hanover, Germany
-
Munich Clinic Bogenhausen
Munich, Germany
-
University Hospital Dresden
Dresden, Germany
-
University Hospital Essen
Essen, Germany
-
University Hospital Halle
Halle, Germany
-
University Hospital Jena
Jena, Germany
-
University Hospital Munich Grosshadern
Munich, Germany
Conditions
Explore the condition pages connected to this study.